Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells

Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells

Naoyuki Akashi,1 Tomio Umemoto,1 Hodaka Yamada,2 Takayuki Fujiwara,3 Kei Yamamoto,1 Yousuke Taniguchi,1 Kenichi Sakakura,1 Hiroshi Wada,1 Shin-ichi Momomura,1 Hideo Fujita1 1Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan; 2Division of Endocrinolo...

Full description

Bibliographic Details
Main Authors: Akashi N, Umemoto T, Yamada H, Fujiwara T, Yamamoto K, Taniguchi Y, Sakakura K, Wada H, Momomura SI, Fujita H
Format: Article
Language:English
Published: Dove Medical Press 2023-04-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
endothelial progenitor cell
teneligliptin
dpp-4 inhibitor
flow-mediated dilation
type 2 diabetes mellitus.
Online Access:https://www.dovepress.com/teneligliptin-a-dpp-4-inhibitor-improves-vascular-endothelial-function-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/teneligliptin-a-dpp-4-inhibitor-improves-vascular-endothelial-function-peer-reviewed-fulltext-article-DMSO

Similar Items